跳至主要内容
临床试验/NCT06347614
NCT06347614进行中(未招募)不适用

Modified Radical Prostatectomy for Prostate Cancer Patients With Enlarged Prostate and Severe Lower Urinary Tract Symptoms: a Single-center, Retrospective Study

Sun Yat-sen University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30
试验地点
1
主要终点
Biochemical Recurrence-free Survival

研究概览

简要总结

The goal of this retrospective, observational study is to preliminarily learn about the safety and efficacy of two-step radical prostatectomy in the treatment of low- to intermediate-risk prostate cancer patients with enlarged prostate and severe benign prostatic hyperplasia. The main questions it aims to answer are: 1. Whether two-step prostatectomy is safe enough to decrease the surgical difficulty of these patients? 2. Whether the oncologic control is promising?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
Male
接受健康志愿者

入选标准

  • Diagnosed as prostate cancer pathologically by prostate biopsy Evaluated as localized prostate cancer by imaging studies Prostate volume>70mL evaluated by transrectal ultrasonography or multi-parametric magnetic resonance imaging Gleason score≤ 4+3=7 Preoperative PSA<20ng/mL Estimated survival> 10 years; Informed consent is obtained from the patient

排除标准

  • The patient has received other therapy including radical radiotherapy, transurethral resection of the prostate, cryoablation, HIFU, etc.
  • Any contraindication of surgery or anaesthesia

结局指标

主要结局

Biochemical Recurrence-free Survival

时间窗: 5 years

Number of participants who are free of biochemical relapse after a specified duration of time. Biochemical recurrence is measured by PSA levels. Biochemical recurrence was defined as a measurable serum PSA concentration 0.2 ng/ml or greater.

次要结局

  • Continence ContinenceContinence Continence Continence Continence Continence Continence Continence Continence(2 weeks, 1 months, 3 months, 6 months, 12 months after surgery)
  • Lower urinary tract symptoms(1 months, 3 months, 6 months, 12 months after surgery)
  • Estimated blood loss(Intraoperative)
  • Erectile function(6 months, 12 months and 24 months after surgery)
  • Positive surgical margin rate(Through study completion, an average of 5 year)
  • Surgical time(Intraoperative)
  • Hospital stay(From date of surgery until the date of discharge, an average of 7 days)
  • Complication(Through study completion, an average of 5 year)

研究者

发起方
Sun Yat-sen University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yonghong Li

Professor

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验